Back to Search Start Over

An outlook on coronavirus disease 2019 detection methods

Authors :
Zahra Hassani Nejad
Fataneh Fatemi
Seyed Ehsan Ranaei Siadat
Source :
Journal of Pharmaceutical Analysis, Vol 12, Iss 2, Pp 205-214 (2022)
Publication Year :
2022
Publisher :
Elsevier, 2022.

Abstract

Diagnostic testing plays a fundamental role in the mitigation and containment of coronavirus disease 2019 (COVID-19), as it enables immediate quarantine of those who are infected and contagious and is essential for the epidemiological characterization of the virus and estimating the number of infected cases worldwide. Confirmation of viral infections, such as COVID-19, can be achieved through two general approaches: nucleic acid amplification tests (NAATs) or molecular tests, and serological or antibody-based tests. The genetic material of the pathogen is detected in NAAT, and in serological tests, host antibodies produced in response to the pathogen are identified. Other methods of diagnosing COVID-19 include radiological imaging of the lungs and in vitro detection of viral antigens. This review covers different approaches available to diagnosing COVID-19 by outlining their advantages and shortcomings, as well as appropriate indications for more accurate testing.

Details

Language :
English
ISSN :
20951779
Volume :
12
Issue :
2
Database :
Directory of Open Access Journals
Journal :
Journal of Pharmaceutical Analysis
Publication Type :
Academic Journal
Accession number :
edsdoj.fcba4ac661714b24a3e6f7089b7835df
Document Type :
article
Full Text :
https://doi.org/10.1016/j.jpha.2021.11.003